Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

PMGC Holdings Inc. - Common Stock (NQ:ELAB)

2.140 -0.060 (-2.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 49,373
Open 2.240
Bid (Size) 2.130 (1)
Ask (Size) 2.230 (50)
Prev. Close 2.200
Today's Range 2.100 - 2.250
52wk Range 2.140 - 970.48
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q
From PMGC Holdings Inc.
Via GlobeNewswire

Performance

YTD
-87.7%
-87.7%
1 Month
-6.1%
-6.1%
3 Month
-80.5%
-80.5%
6 Month
-90.4%
-90.4%
1 Year
-99.8%
-99.8%

More News

Read More
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)
From PMGC Holdings Inc.
Via GlobeNewswire
Northstrive Biosciences Signs Binding Term Sheet with Modulant Biosciences for Exclusive Global Animal Health Licensing of EL-22
From PMGC Holdings Inc.
Via GlobeNewswire
RESEND - Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health
From PMGC Holdings Inc.
Via GlobeNewswire
Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health
From PMGC Holdings Inc.
Via GlobeNewswire
Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial
From PMGC Holdings Inc.
Via GlobeNewswire
Thursday's session: top gainers and losers
Via Chartmill
Keep an eye on the top gainers and losers in Thursday's session.
Via Chartmill
Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment
From PMGC Holdings Inc.
Via GlobeNewswire
What's going on in today's pre-market session
Via Chartmill
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company
From PMGC Holdings Inc.
Via GlobeNewswire
Top stock movements in today's session.
Via Chartmill
PMGC Stock Surges After Subsidiary Inks Deal With Yuva Biosciences To Develop AI Led Therapies
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Which stocks are moving before the opening bell on Thursday?
Via Chartmill
Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K
From PMGC Holdings Inc.
Via GlobeNewswire
NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market
From PMGC Holdings Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Friday's After-Market Session
Via Benzinga
PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Announces Share Repurchases from Existing Shareholders
From PMGC Holdings Inc.
Via GlobeNewswire
Which stocks are gapping on Thursday?
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session.
Via Chartmill
Monday's session: top gainers and losers
Via Chartmill

Frequently Asked Questions

Is PMGC Holdings Inc. - Common Stock publicly traded?
Yes, PMGC Holdings Inc. - Common Stock is publicly traded.
What exchange does PMGC Holdings Inc. - Common Stock trade on?
PMGC Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PMGC Holdings Inc. - Common Stock?
The ticker symbol for PMGC Holdings Inc. - Common Stock is ELAB on the Nasdaq Stock Market
What is the current price of PMGC Holdings Inc. - Common Stock?
The current price of PMGC Holdings Inc. - Common Stock is 2.140
When was PMGC Holdings Inc. - Common Stock last traded?
The last trade of PMGC Holdings Inc. - Common Stock was at 06/03/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.